<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Pain Practice via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Pain Practice' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Pain+Practice&t=Pain+Practice&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 07:39:23 +0100</lastBuildDate>
        <item>
            <title>A Randomized, Double‐Blind Comparison Shows the Addition of Oxygenated Glycerol Triesters to Topical Mentholated Cream for the Treatment of Acute Musculoskeletal Pain Demonstrates Incremental Benefit Over Time</title>
            <link>http://www.medworm.com/index.php?rid=5666597&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2012.00529.x</link>
            <description>Conclusion:  Based on this study, a MC containing OGTs is safe, effective, and provided significantly better pain relief than MC alone. The combination of oxygenated glycerol trimesters and MC provided significant pain relief and offered continued improvement in pain relief over time. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666597</comments>
            <pubDate>Sun, 05 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5666597</guid>        </item>
        <item>
            <title>Modulation of Somatosensory Profiles by Spinal Cord Stimulation in Primary Raynaud′s Syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5666596&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2012.00531.x</link>
            <description>Conclusion: SCS significantly modulated the somatosensory profile in a patient with primary Raynaud′s syndrome. These effects were pronounced in qualities involving Aβ, C, and A∂ nerve fibers. Further investigations may help to understand the mechanisms of action of SCS. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666596</comments>
            <pubDate>Sun, 05 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5666596</guid>        </item>
        <item>
            <title>Use and Costs of Prescription Medications and Alternative Treatments in Patients with Osteoarthritis and Chronic Low Back Pain in Community‐Based Settings</title>
            <link>http://www.medworm.com/index.php?rid=5666595&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2012.00532.x</link>
            <description>Conclusions:  Patients with OA and CLBP used a variety of pain‐related and adjunctive medications. Although, alternative treatments are widely recommended, we found limited use of several of these in clinical practice, potentially due to the source of our data (commercial claims). Further research is needed to ascertain the extent to which such therapies contribute to the total costs of OA and CLBP management. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666595</comments>
            <pubDate>Sun, 05 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5666595</guid>        </item>
        <item>
            <title>The Long‐Term Outcome of Transcutaneous Electrical Nerve Stimulation in the Treatment for Patients with Chronic Pain: A Randomized, Placebo‐Controlled Trial</title>
            <link>http://www.medworm.com/index.php?rid=5666594&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2012.00533.x</link>
            <description>Conclusions:  Transcutaneous electrical nerve stimulation and sham TENS show similar effects in patients with chronic pain over a period of 1 year. We found support for a long sustained placebo effect. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666594</comments>
            <pubDate>Sun, 05 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5666594</guid>        </item>
        <item>
            <title>A Comprehensive Review of Telehealth for Pain Management: Where We Are and The Way Ahead</title>
            <link>http://www.medworm.com/index.php?rid=5666593&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2012.00534.x</link>
            <description>AbstractPain is generally undertreated in the United States, owing to a number of barriers including geographic distance from specialty treatment providers; functional disability that limits mobility; treatment‐related stigma; economic limitations; and educational barriers. Pain undertreatment exacerbates pain chronicity and emotional disruption that can significantly erode a pain patient’s quality of life, and there is widespread agreement that pain care must evolve to address this significant problem. The growing field of telehealth (defined for the purposes of this paper as technology that allows for distance interaction between providers and/or patients) offers a novel opportunity to expand pain assessment, consultation, and treatment services beyond the walls of the specialty pain...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666593</comments>
            <pubDate>Sun, 05 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5666593</guid>        </item>
        <item>
            <title>Healthcare Costs Associated with Osteoarthritis in US Patients</title>
            <link>http://www.medworm.com/index.php?rid=5666592&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2012.00535.x</link>
            <description>Conclusion:  Newly diagnosed osteoarthritis patients incurred higher annual costs, but lower pain‐related prescription drug costs in the year following diagnosis than patients with existing osteoarthritis. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666592</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5666592</guid>        </item>
        <item>
            <title>Chronic Female Pelvic Pain—Part 2: Differential Diagnosis and Management</title>
            <link>http://www.medworm.com/index.php?rid=5659295&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00492.x</link>
            <description>Abstract:  Pelvic pain is a common condition. Treatment interventions have traditionally targeted biomedical conditions with variable success. Utilizing a systematic approach to examination of the pelvic girdle and related organ systems contained within the pelvis will aid the clinician in identifying the painful structure(s) as well as the associated impairments limiting functional recovery. From this, a complete management program can be instituted. The following description of gynecologic, urologic, gastrointestinal, musculoskeletal, and neurologic conditions that can cause or are associated with chronic pelvic pain leads to conservative management proposals based on the available evidence. Finally, nonoperative interventional strategies are described, which target the pain system fro...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659295</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5659295</guid>        </item>
        <item>
            <title>Chronic Pelvic Pain: Is It Time for an Algorithmic Approach?</title>
            <link>http://www.medworm.com/index.php?rid=5659294&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00523.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659294</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5659294</guid>        </item>
        <item>
            <title>Adherence with Migraine Prophylaxis in Clinical Practice</title>
            <link>http://www.medworm.com/index.php?rid=5659293&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2012.00530.x</link>
            <description>Conclusion:  Our findings suggest that many patients who begin migraine prophylaxis with antidepressants, antiepileptics, or beta blockers are no longer taking these medications at 6 months. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659293</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5659293</guid>        </item>
        <item>
            <title>A Double‐blind, Randomized, Prospective Study of Epidural Steroid Injection vs. The mild® Procedure in Patients with Symptomatic Lumbar Spinal Stenosis</title>
            <link>http://www.medworm.com/index.php?rid=5627927&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00518.x</link>
            <description>Conclusions:  This study demonstrated that in LSS patients suffering with neurogenic claudication, mild provides statistically significantly better pain reduction and improved functional mobility vs. treatment with ESI. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5627927</comments>
            <pubDate>Thu, 26 Jan 2012 12:10:25 +0100</pubDate>
            <guid isPermaLink="false">5627927</guid>        </item>
        <item>
            <title>6th World Congress‐World Institute of Pain</title>
            <link>http://www.medworm.com/index.php?rid=5607851&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00528.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5607851</comments>
            <pubDate>Fri, 20 Jan 2012 12:11:22 +0100</pubDate>
            <guid isPermaLink="false">5607851</guid>        </item>
        <item>
            <title>Successful Dose Finding with Sublingual Fentanyl Tablet: Combined Results from 2 Open‐Label Titration Studies</title>
            <link>http://www.medworm.com/index.php?rid=5580785&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00525.x</link>
            <description>Conclusion:  Despite stringent criteria, 64.4% of patients achieved an effective dose of fentanyl sublingual tablet within the dose range of 100 to 800 μg. Baseline characteristics were not identified to be associated with the likelihood of successful titration or with the actual effective dose of fentanyl sublingual tablet. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5580785</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5580785</guid>        </item>
        <item>
            <title>Real‐World Role of Tricyclic Antidepressants in the Treatment of Fibromyalgia</title>
            <link>http://www.medworm.com/index.php?rid=5580784&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00526.x</link>
            <description>Discussion:  Research covering 1999 to 2005 using the same methods found that 15.9% of patients with FM used TCAs during the year before FM diagnosis and 20.7% used TCAs during the year after. These findings suggest that TCA use among the patients with FM is uncommon and may be declining in real‐world practice. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5580784</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5580784</guid>        </item>
        <item>
            <title>The Term of Functional Somatic Syndrome Should be Changed to the Term of Central Sensitivity Syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5580788&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00504.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5580788</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5580788</guid>        </item>
        <item>
            <title>Re: Pergolizzi et al. 2011: Exposure to potential CYP450 pharmacokinetic drug–drug interactions</title>
            <link>http://www.medworm.com/index.php?rid=5580787&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00506.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5580787</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5580787</guid>        </item>
        <item>
            <title>Ultrasound‐Guided Hip Joint Injections: A New Scanning Routine for Easy Methodical Training</title>
            <link>http://www.medworm.com/index.php?rid=5580786&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00505.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5580786</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5580786</guid>        </item>
        <item>
            <title>Therapy Switching, Augmentation, and Discontinuation in Patients with Osteoarthritis and Chronic Low Back Pain</title>
            <link>http://www.medworm.com/index.php?rid=5580783&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00524.x</link>
            <description>Conclusions:  This study demonstrates that therapy switching and discontinuation of select pain medications were common among OA and CLBP patients in the U.K. and may result from inadequate pain relief or undesirable side effects. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5580783</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5580783</guid>        </item>
        <item>
            <title>Gastrointestinal Effects of the Addition of Ascorbic Acid to Aspirin</title>
            <link>http://www.medworm.com/index.php?rid=5486266&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00517.x</link>
            <description>AbstractNonsteroidal anti‐inflammatory drugs (NSAIDs), including aspirin, have been associated with the damage to the gastrointestinal tract. One proposed mechanism of injury to the gastrointestinal mucosa by NSAIDs is oxygen radical‐dependent microvascular injury. There is reasonable evidence to support the benefit of the addition of ascorbic acid, an ingredient with antioxidant properties, to moderate the adverse gastrointestinal (GI) effects of aspirin. Pharmacokinetic data have demonstrated that aspirin and ascorbic acid combination therapy can assist in mitigating the decrease in levels of ascorbic acid secondary to aspirin monotherapy. Endoscopic evaluation has demonstrated that the addition of ascorbic acid to aspirin significantly improves Lanza scores and rates of blood loss w...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486266</comments>
            <pubDate>Wed, 07 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5486266</guid>        </item>
        <item>
            <title>Investigation of Nonmechanical Findings during Spinal Movement Screening for Identifying and/or Ruling Out Metastatic Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5440227&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00519.x</link>
            <description>Conclusion:  Nonmechanical findings during a traditional movement screen are not specific to sinister conditions such as metastatic spinal cancer. Clinicians should expect concomitant conditions to exhibit painful or limited findings in patients with and without cancer. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5440227</comments>
            <pubDate>Tue, 22 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5440227</guid>        </item>
        <item>
            <title>Type of Interventional Pain Procedure, Body Weight, and Presence of Spinal Pathology are Determinants of the Level of Radiation Exposure for Fluoroscopically Guided Pain Procedures</title>
            <link>http://www.medworm.com/index.php?rid=5537347&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00521.x</link>
            <description>Abstract:  In the recent years new technology has led to the development of a bewildering array of imaging procedures. Yet, conventional radiography remains one of the most used tools to diagnose and to aid procedural interventions. Fluoroscopy guidance facilitates targeted drug delivery or radiofrequency directly to the area of pathology, a benefit that has to be balanced against the risks of radiation exposure. In this prospective observational survey of routine practice, dose area product (DAP) and screening time (ST) were recorded in 127 consecutive patients undergoing fluoroscopically guided spinal procedures along with other probable measures of potentially greater radiation exposure such as weight, type of spinal pathology, the ease of recognition of the anatomical landmarks, and ...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5537347</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5537347</guid>        </item>
        <item>
            <title>Treatment of Meralgia Paresthetica with Ultrasound‐Guided Pulsed Radiofrequency Ablation of the Lateral Femoral Cutaneous Nerve</title>
            <link>http://www.medworm.com/index.php?rid=5486265&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00522.x</link>
            <description>Abstract:  A 23‐year‐old female with an 18‐month history of left anterolateral thigh paresthesias and burning pain consistent with meralgia paresthetica was referred to our clinic after failing trials of physical therapy, nonsteroidal anti‐inflammatories, gabapentin, and amitriptyline. We performed 3 lateral femoral cutaneous nerve blocks with corticosteroid over a 4‐month period; however, each block provided only temporary relief. As this pain was limiting the patient’s ability to perform her functions as an active duty service member, we elected to perform a pulsed radiofrequency treatment of the lateral femoral cutaneous nerve with ultrasound guidance and nerve stimulation. After locating the lateral femoral cutaneous nerve with ultrasound and reproducing the patient’s d...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486265</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5486265</guid>        </item>
        <item>
            <title>A Review of Opioid Prescribing Practices and Associations with Repeat Opioid Prescriptions in a Contemporary Outpatient HIV Clinic</title>
            <link>http://www.medworm.com/index.php?rid=5440226&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00520.x</link>
            <description>Conclusions:  Advanced HIV disease and greater medical and neuropsychiatric comorbidity predict repeat opioid prescribing, and these findings reflect the underlying complexities in managing pain symptoms in this population. We also highlight multiple deficiencies in opioid prescribing practices and nonadherence to guidelines, which are of concern as effective and safe pain management for our HIV‐infected population is an optimal goal. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5440226</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5440226</guid>        </item>
        <item>
            <title>Acknowledgements</title>
            <link>http://www.medworm.com/index.php?rid=5384191&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00516.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5384191</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5384191</guid>        </item>
        <item>
            <title>The Neuropathic Pain Diagnosed With the Grading System is Different from Pain Defined With the Definition of Neuropathic Pain</title>
            <link>http://www.medworm.com/index.php?rid=5384190&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00500.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5384190</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5384190</guid>        </item>
        <item>
            <title>Full‐thickness local soft tissue atrophy following steroid injection to greater occipital nerve</title>
            <link>http://www.medworm.com/index.php?rid=5384189&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00501.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5384189</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5384189</guid>        </item>
        <item>
            <title>The Coronary Sinus Reducer Stent for the Treatment of Chronic Angina Pectoris</title>
            <link>http://www.medworm.com/index.php?rid=5384188&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00502.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5384188</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5384188</guid>        </item>
        <item>
            <title>The Pain Impact Inventory—Further Validation in Various Subgroups</title>
            <link>http://www.medworm.com/index.php?rid=5334872&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00511.x</link>
            <description>Conclusion:  The PII showed satisfactory psychometric properties in terms of construct validity and reliability with regard to gender, age‐groups, and primary pain location. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5334872</comments>
            <pubDate>Wed, 19 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5334872</guid>        </item>
        <item>
            <title>Pain Relief in Laparoscopic Cholecystectomy—A Review of the Current Options</title>
            <link>http://www.medworm.com/index.php?rid=5334871&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00513.x</link>
            <description>Abstract:  Pain relief after laparoscopic cholecystectomy (LC) is an issue of great practical importance. Pain after LC has several origins: incisional, local visceral, peritoneal, and referred. Several modalities have been employed for achieving effective and safe analgesia: nonsteroidal anti‐inflammatory drugs (NSAIDs) and cyclooxygenase‐2 (COX‐2) inhibitors, gabapentinoids, local anesthetics, and transversus abdominis plane (TAP) block. They have their advantages and disadvantages, and multimodal approaches are often followed because of the multiple sources of pain. Among COX‐2 inhibitors, parecoxib and valdecoxib are useful, and fears regarding their cardiovascular adverse effects in noncardiac surgery (such as LC) have not been substantiated when used in short term. Gabapent...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5334871</comments>
            <pubDate>Wed, 19 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5334871</guid>        </item>
        <item>
            <title>Intradiscal Pulsed Radiofrequency Application Following Provocative Discography for the Management of Degenerative Disc Disease and Concordant Pain: A Pilot Study</title>
            <link>http://www.medworm.com/index.php?rid=5334870&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00512.x</link>
            <description>Abstract:  The development of diagnostic criteria and the use of provocative discography allow identifying the degenerative disc as causative structure for chronic low‐back pain. Unfortunately, none of the available interventional treatment options have been demonstrated to be effective over a prolonged period of time for a considerable number of patients.Pathophysiological studies indicate sprouting of sensory nerves and inflammatory processes as underlying pain mechanisms.Pulsed radiofrequency (PRF) treatment in small and larger joints was described to reduce pain and improve healing by stimulating the immunology. Earlier findings of PRF applied in the disc annulus were promising. It is assumed that PRF applied in the nucleus would change the conductivity of nerve endings and provide...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5334870</comments>
            <pubDate>Wed, 19 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5334870</guid>        </item>
        <item>
            <title>Costs and Health Resources Utilization Following Switching to Pregabalin in Individuals with Gabapentin‐Refractory Neuropathic Pain: A post hoc Analysis</title>
            <link>http://www.medworm.com/index.php?rid=5334873&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00515.x</link>
            <description>Conclusions:  The cost of care in patients with gabapentin‐refractory peripheral neuropathic pain appeared to be significantly reduced after switching to pregabalin treatment, alone or in combination with other analgesic drugs, in a real‐life setting. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5334873</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5334873</guid>        </item>
        <item>
            <title>The Development and Psychometric Validation of the Central Sensitization Inventory</title>
            <link>http://www.medworm.com/index.php?rid=5259917&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00493.x</link>
            <description>Abstract:Central sensitization (CS) has been proposed as a common pathophysiological mechanism to explain related syndromes for which no specific organic cause can be found. The term “central sensitivity syndrome (CSS)” has been proposed to describe these poorly understood disorders related to CS. The goal of this investigation was to develop the Central Sensitization Inventory (CSI), which identifies key symptoms associated with CSSs and quantifies the degree of these symptoms. The utility of the CSI, to differentiate among different types of chronic pain patients who presumably have different levels of CS impairment, was then evaluated. Study 1 demonstrated strong psychometric properties (test–retest reliability = 0.817; Cronbach’s alpha = 0.879) of the CSI in a cohort of...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5259917</comments>
            <pubDate>Mon, 26 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5259917</guid>        </item>
        <item>
            <title>Predictors of Duloxetine versus Other Treatments among Veterans with Diabetic Peripheral Neuropathic Pain: A Retrospective Study</title>
            <link>http://www.medworm.com/index.php?rid=5259916&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00494.x</link>
            <description>Conclusion:  DPNP patients in the VA healthcare system with prior other treatment use, select comorbid conditions, prior substance abuse, prior opioid use, and higher pain level were more likely to receive duloxetine. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5259916</comments>
            <pubDate>Mon, 26 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5259916</guid>        </item>
        <item>
            <title>Comparative Effectiveness in Pain‐Related Outcomes and Health Care Utilizations between Veterans with Major Depressive Disorder Treated with Duloxetine and Other Antidepressants: A Retrospective Propensity Score‐Matched Comparison</title>
            <link>http://www.medworm.com/index.php?rid=5259915&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00495.x</link>
            <description>Conclusion:  Controlling for cross‐cohort differences, veterans with MDD treated with duloxetine were associated with lower risks of opioid use and substance abuse and lower health care utilization than those treated with other antidepressants. ▪ (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5259915</comments>
            <pubDate>Mon, 26 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5259915</guid>        </item>
        <item>
            <title>The Evolution of Pain Treatment: Is it all about Money?</title>
            <link>http://www.medworm.com/index.php?rid=5224517&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00496.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5224517</comments>
            <pubDate>Fri, 16 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5224517</guid>        </item>
        <item>
            <title>The Peridural Membrane of the Spinal Canal: A Critical Review</title>
            <link>http://www.medworm.com/index.php?rid=5346700&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00510.x</link>
            <description>Abstract:  There exists substantial evidence that a peridural membrane (PM) is present in the spinal canal of humans and, like the pleura and peritoneum, has one or more physiologic functions. Innervation of the PM suggests that it may become a source of pain if injured. Although debated, the physiology of this structure has important implications with respect to neuraxial distribution of drugs and for back and radiating pain. This review, separated into embryological, anatomic, and physiologic discussions, provides an in‐depth summary of the observations of this connective tissue. The discrepancies between accounts are highlighted within each section. Focused research to clearly elucidate the true nature of the PM, especially as related to neuraxial distribution of drugs and back and ...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5346700</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5346700</guid>        </item>
        <item>
            <title>Intravenous Acetaminophen for Pain after Major Orthopedic Surgery: An Expanded Analysis</title>
            <link>http://www.medworm.com/index.php?rid=5334869&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00514.x</link>
            <description>Conclusion:  Repeated‐dose 24‐hours end points were found to be as robust as previously published results. IV acetaminophen efficacy and safety appeared to be unaffected by specific subset variables.▪ (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5334869</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5334869</guid>        </item>
        <item>
            <title>The Pterygopalatine Ganglion and its Role in Various Pain Syndromes: From Anatomy to Clinical Practice</title>
            <link>http://www.medworm.com/index.php?rid=5273044&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00507.x</link>
            <description>Abstract  The postsynaptic fibers of the pterygopalatine or sphenopalatine ganglion (PPG or SPG) supply the lacrimal and nasal glands. The PPG appears to play an important role in various pain syndromes including headaches, trigeminal and sphenopalatine neuralgia, atypical facial pain, muscle pain, vasomotor rhinitis, eye disorders, and herpes infection. Clinical trials have shown that these pain disorders can be managed effectively with sphenopalatine ganglion blockade (SPGB). In addition, regional anesthesia of the distribution area of the SPG sensory fibers for nasal and dental surgery can be provided by SPGB via a transnasal, transoral, or lateral infratemporal approach. To arouse the interest of the modern‐day clinicians in the use of the SPGB, the advantages, disadvantages, and m...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5273044</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5273044</guid>        </item>
        <item>
            <title>Economic Impact of Potential Drug–Drug Interactions among Osteoarthritis Patients Taking Opioids</title>
            <link>http://www.medworm.com/index.php?rid=5259914&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00498.x</link>
            <description>This study compared patients with and without such an incident DDE to determine healthcare utilization and associated payments. Using a retrospective database analysis, the impact of DDEs was evaluated in terms of associated clinical events, healthcare services utilization (office visits, outpatient visits, ED visits, hospitalization), and payments in patient populations based on age (those under age 65 and those 65 years of age and older), during the 6 months after exposure. DDE patients had significantly more inpatient hospitalizations than no‐DDE patients. Mean total payments at 6 months were significantly higher for both younger and older patients with DDE compared to similar patients without DDE ($9,469, SD = $12,192 vs. $8,382, SD = $14,078, respectively, for younger ...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5259914</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5259914</guid>        </item>
        <item>
            <title>Re: Coccygodynia</title>
            <link>http://www.medworm.com/index.php?rid=5224521&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00486.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5224521</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5224521</guid>        </item>
        <item>
            <title>In Response: Intravenous Regional Guanethidine for Complex Regional Pain Syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5224520&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00483.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5224520</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5224520</guid>        </item>
        <item>
            <title>Intravenous Regional Guanethidine Block without Local Anaesthesia for Complex Regional Pain Syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5224519&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00482.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5224519</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5224519</guid>        </item>
        <item>
            <title>Evidence‐Based Interventional Pain Medicine According to Clinical Diagnoses</title>
            <link>http://www.medworm.com/index.php?rid=5224518&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00490.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5224518</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5224518</guid>        </item>
        <item>
            <title>Economic Impact of Potential CYP450 Pharmacokinetic Drug–Drug Interactions Among Chronic Low Back Pain Patients Taking Opioids</title>
            <link>http://www.medworm.com/index.php?rid=5224516&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00503.x</link>
            <description>This study compared utilization of healthcare resources and associated payments in cLBP patients with and without incident DDEs with the potential to cause PK DDIs. A retrospective database analysis examined the associated clinical events, healthcare utilization (measured in terms of claims for office visits, outpatient visits, emergency department visits, and hospitalization), and cost to the health plan, as defined as the sum of health plan payments for resources used. Patients were grouped into 2 cohorts by age (those under 65 and those 65 years and over). In the 6 months after exposure, total healthcare payments were significantly higher for DDE patients than those without DDEs (no‐DDE), in both in the younger ($7,086, SD = $8,370) and $6,353, SD = $8,352, respectively, P...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5224516</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5224516</guid>        </item>
        <item>
            <title>Pharmacological Treatment of Neuropathic Cancer Pain: A Comprehensive Review of the Current Literature</title>
            <link>http://www.medworm.com/index.php?rid=5078380&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00485.x</link>
            <description>Abstract:Neuropathic cancer pain (NCP), commonly encountered in clinical practice, may be cancer‐related, namely resulting from nervous system tumor invasion, surgical nerve damage during tumor removal, radiation‐induced nerve damage and chemotherapy‐related neuropathy, or may be of benign origin, unrelated to cancer. A neuropathic component is evident in about 1/3 of cancer pain cases. Although from a pathophysiological perspective NCP may differ from chronic neuropathic pain (NP), such as noncancer‐related pain, clinical practice, and limited publications have shown that these two pain entities may share some treatment modalities. For example, co‐analgesics have been well integrated into cancer pain‐management strategies and are often used as First‐Line options for the trea...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5078380</comments>
            <pubDate>Thu, 28 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5078380</guid>        </item>
        <item>
            <title>Current Considerations for the Treatment of Severe Chronic Pain: The Potential for Tapentadol</title>
            <link>http://www.medworm.com/index.php?rid=5078379&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00487.x</link>
            <description>Abstract  Studies suggest that around 20% of adults in Europe experience chronic pain, which not only has a considerable impact on their quality of life but also imposes a substantial economic burden on society. More than one‐third of these people feel that their pain is inadequately managed. A range of analgesic drugs is currently available, but recent guidelines recommend that NSAIDs and COX‐2 inhibitors should be prescribed cautiously. Although the short‐term efficacy of opioids is good, adverse events are common and doses are frequently limited by tolerability problems. There is a perceived need for improved pharmacological treatment options.Currently, many treatment decisions are based solely on pain intensity. However, chronic pain is multifactorial and this apaproach ignores...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5078379</comments>
            <pubDate>Thu, 28 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5078379</guid>        </item>
        <item>
            <title>Measuring Functioning in People with Fibromyalgia (FM) Based on the International Classification of Functioning, Disability and Health (ICF)—A Psychometric Analysis</title>
            <link>http://www.medworm.com/index.php?rid=5078378&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00488.x</link>
            <description>Conclusions:  This study illustrates that it is possible to measure functioning as a unidimensional construct based on selected ICF categories from the components body functions, as well as activities and participation of the Brief ICF‐Core‐Set for CWP in patients with FM. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5078378</comments>
            <pubDate>Thu, 28 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5078378</guid>        </item>
        <item>
            <title>Predictors of Pain Medication Selection Among Patients Diagnosed with Fibromyalgia</title>
            <link>http://www.medworm.com/index.php?rid=5207595&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00497.x</link>
            <description>Conclusions:  The presence of select comorbidities and prior use of certain medications were associated with the duloxetine initiation among working‐age, commercially insured patients with fibromyalgia. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5207595</comments>
            <pubDate>Fri, 01 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5207595</guid>        </item>
        <item>
            <title>Malignant Pheochromocytoma Presenting as Incapacitating Bony Pain</title>
            <link>http://www.medworm.com/index.php?rid=5183080&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00499.x</link>
            <description>Abstract:  Among adrenal incidentalomas, pheochromocytomas are rare. Malignant pheochromocytoma is even less common, and it typically presents with classic hormonal symptoms, such as palpitations, labile blood pressures, and headaches. Bony metastasis usually occurs late in disease, but we report an unusual case of incapacitating bony pain as the initial presentation of malignant pheochromocytoma. Our patient is a 70‐year‐old woman with neurofibromatosis type 1 and a history of primary hyperparathyroidism, who tested negative for the ret mutation. She came to medical attention with chest pain and palpitations and was incidentally found to have an adrenal mass. Serum and urine testing was consistent with pheochromocytoma. Her blood pressure was easily controlled as she awaited electiv...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5183080</comments>
            <pubDate>Thu, 30 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5183080</guid>        </item>
        <item>
            <title>Pharmacokinetics of Fentanyl Buccal Tablet: A Pooled Analysis and Review</title>
            <link>http://www.medworm.com/index.php?rid=5108812&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00491.x</link>
            <description>AbstractFentanyl buccal tablet (FBT) is indicated for the treatment of breakthrough pain in patients who are already receiving and are tolerant to opioid therapy for underlying, persistent cancer pain. FBT is designed to enhance the rate and efficiency of absorption of fentanyl through the buccal mucosa. FBT was shown to be dose proportional from 100 to 1,300 μg. This analysis provides an overview of the pharmacokinetic profile of FBT based on pooled data from nine pharmacokinetic studies. In all, 365 healthy non‐opioid‐tolerant adults receiving naltrexone were included in the analysis. Single‐dose (100 to 1,300 μg) pharmacokinetic parameters were dose normalized to 100 μg. Pharmacokinetic measures included maximum observed plasma drug concentration (Cmax), plasma drug conce...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5108812</comments>
            <pubDate>Thu, 30 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5108812</guid>        </item>
        <item>
            <title>Chronic Female Pelvic Pain, Part 2: Differential Diagnosis and Management</title>
            <link>http://www.medworm.com/index.php?rid=5087114&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00492.x</link>
            <description>Abstract:Pelvic pain is a common condition. Treatment interventions have traditionally targeted biomedical conditions with variable success. Utilizing a systematic approach to examination of the pelvic girdle and related organ systems contained within the pelvis will aid the clinician in identifying the painful structure(s) as well as the associated impairments limiting functional recovery. From this, a complete management program can be instituted. The following description of gynecologic, urologic, gastrointestinal, musculoskeletal, and neurologic conditions that can cause or are associated with chronic pelvic pain leads to conservative management proposals based on the available evidence. Finally, nonoperative interventional strategies are described, which target the pain system from a ...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5087114</comments>
            <pubDate>Thu, 30 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5087114</guid>        </item>
        <item>
            <title>Is Spinal Cord Stimulation an Effective Treatment Option for Discogenic Pain?</title>
            <link>http://www.medworm.com/index.php?rid=5078377&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00489.x</link>
            <description>Conclusions:  The current study indicates that SCS may provide effective pain relief, improve disability, and reduce opioid usage in patients with discogenic pain. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5078377</comments>
            <pubDate>Thu, 30 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5078377</guid>        </item>
        <item>
            <title>The Term “Psychogenic Pain” should be Abolished or Changed to “Braingenic Pain” (Pain Whose Affected Area is in the Brain)</title>
            <link>http://www.medworm.com/index.php?rid=5009375&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00471.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5009375</comments>
            <pubDate>Thu, 30 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5009375</guid>        </item>
        <item>
            <title>Medication Management in the Elderly Population: In Search of the Right Balance</title>
            <link>http://www.medworm.com/index.php?rid=5009374&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00484.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5009374</comments>
            <pubDate>Thu, 30 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5009374</guid>        </item>
        <item>
            <title>26. Pain in Chronic Pancreatitis</title>
            <link>http://www.medworm.com/index.php?rid=4936029&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00474.x</link>
            <description>Abstract:  Chronic pancreatitis is defined as a progressive inflammatory response of the pancreas that has lead to irreversible morphological changes of the parenchyma (fibrosis, loss of acini and islets of Langerhans, and formation of pancreatic stones) as well as of the pancreatic duct (stenosis and pancreatic stones). Pain is one of the most important symptoms of chronic pancreatitis. The pathogenesis of this pain can only partly be explained and it is therefore often difficult to treat this symptom.The management of pain induced by chronic pancreatitis starts with lifestyle changes and analgesics.For the pharmacological management, the three‐step ladder of the World Health Organization extended with the use of co‐analgesics is followed.Interventional pain management may consist o...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4936029</comments>
            <pubDate>Wed, 15 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4936029</guid>        </item>
        <item>
            <title>Successful Reversal of Hyperalgesia/Myoclonus Complex with Low‐Dose Ketamine Infusion</title>
            <link>http://www.medworm.com/index.php?rid=4936028&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00475.x</link>
            <description>We report the successful use of low‐dose ketamine infusion for treating a severe episode of painful myoclonus in the lower extremities, associated with opioid‐induced hyperalgesia (OIH), in a patient who was receiving long‐term, high dose intrathecal hydromorphone therapy. A low‐dose ketamine infusion immediately relieved the painful myoclonus. It also enabled a reduction in the intrathecal opioid dosage leading to a resolution of the acute symptoms attributed to OIH. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4936028</comments>
            <pubDate>Wed, 15 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4936028</guid>        </item>
        <item>
            <title>Continuous Multimechanistic Postoperative Analgesia: A Rationale for Transitioning from Intravenous Acetaminophen and Opioids to Oral Formulations</title>
            <link>http://www.medworm.com/index.php?rid=4936027&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00476.x</link>
            <description>Abstract:  Good surgical outcomes depend in part on good pain relief, allowing for early mobilization, optimal recovery, and patient satisfaction. Postsurgical pain has multiple mechanisms, and multimechanistic approaches to postoperative analgesia are recommended and may be associated with improved pain relief, lowered opioid doses, and sometimes a lower rate of opioid‐associated side effects. Acetaminophen (paracetamol) is a familiar agent for treating many types of pain, including postsurgical pain. Oral acetaminophen has been shown to be safe and effective in a variety of acute pain models. Combination products using a fixed‐dose of acetaminophen and an opioid have also been effective in treating postsurgical pain. Combination products with acetaminophen have demonstrated an opio...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4936027</comments>
            <pubDate>Wed, 15 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4936027</guid>        </item>
        <item>
            <title>High Doses of Topical Amitriptyline in Neuropathic Pain: Two Cases and Literature Review</title>
            <link>http://www.medworm.com/index.php?rid=4936026&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00477.x</link>
            <description>Abstract:  Severe chronic neuropathic pain is a challenge to treat, and due to adverse effects of classical oral medication, optimal and effective dose levels are difficult to reach. Therefore, administration of topical analgesics might be an option, due to reduced adverse effects, and increased patient compliance.The aim of this article is to describe two cases treated effectively with topical amitriptyline 5% and 10%, the highest dosage described to date. The first patient was a 39‐year‐old man, suffering from severe intractable neuropathic pain in feet and hands, due to diabetes mellitus type II (DM‐II). After application of amitriptyline 5% the patient experienced a complete relieve only in the hands, whereas after application of amitriptyline 10%, a total reduction of pain occ...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4936026</comments>
            <pubDate>Wed, 15 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4936026</guid>        </item>
        <item>
            <title>Health Care Costs in Patients with Painful Diabetic Peripheral Neuropathy Prescribed Pregabalin or Duloxetine</title>
            <link>http://www.medworm.com/index.php?rid=4936025&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00478.x</link>
            <description>Conclusion:  No differences were noted in all‐cause costs attributable to pregabalin or duloxetine. Although patients receiving pregabalin had a significantly greater pre‐ to post‐index increase in pDPN‐related health care costs compared with patients receiving duloxetine, this may have been due to an imbalance in patient exclusion criteria between cohorts. ▪ (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4936025</comments>
            <pubDate>Wed, 15 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4936025</guid>        </item>
        <item>
            <title>HLA‐B*1502 Strongly Predicts Carbamazepine‐Induced Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain</title>
            <link>http://www.medworm.com/index.php?rid=4936024&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00479.x</link>
            <description>Conclusions: HLA‐B*1502 is a strong genetic marker for CBZ‐induced SJS/TEN in Thai patients with neuropathic pain. The screening for this marker should be performed prior to initiation of CBZ treatment to assess the risk of this serious side effect. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4936024</comments>
            <pubDate>Wed, 15 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4936024</guid>        </item>
        <item>
            <title>Preoperative Gabapentin for Acute Post‐thoracotomy Analgesia: A Randomized, Double‐Blinded, Active Placebo‐Controlled Study</title>
            <link>http://www.medworm.com/index.php?rid=4936023&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00480.x</link>
            <description>Conclusions:  A single preoperative oral dose of gabapentin (600 mg) did not reduce pain scores or opioid consumption following elective thoracotomy, and did not confer any analgesic benefit in the setting of effective multimodal analgesia that included thoracic epidural infusion. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4936023</comments>
            <pubDate>Wed, 15 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4936023</guid>        </item>
        <item>
            <title>Long‐Term Results of Percutaneous Lumbar Decompression mild® for Spinal Stenosis</title>
            <link>http://www.medworm.com/index.php?rid=4936022&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00481.x</link>
            <description>Conclusions:  At 1 year this 58‐patient cohort demonstrated continued excellent safety profile of the mild® procedure and equally important, showed long‐term pain relief and improved functionality. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4936022</comments>
            <pubDate>Wed, 15 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4936022</guid>        </item>
        <item>
            <title>Epidural Steroid and Clonidine for Chronic Intractable Post‐thoracotomy Pain: A Pilot Study</title>
            <link>http://www.medworm.com/index.php?rid=4872891&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00469.x</link>
            <description>Discussion:  Our preliminary data suggest possible efficacy of thoracic epidural steroid and clonidine mixture in the treatment of chronic post‐thoracotomy pain. No serious adverse effects were noted in this pilot study. ▪ (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4872891</comments>
            <pubDate>Wed, 25 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4872891</guid>        </item>
        <item>
            <title>Early Ultrasound‐Guided Neurolysis for Pain Management in Gastrointestinal and Pelvic Malignancies: An Observational Study in a Tertiary Care Center of Urban India</title>
            <link>http://www.medworm.com/index.php?rid=4872890&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00467.x</link>
            <description>This article presents our hospital‐based in‐patient palliative care unit experience with early ultrasonography‐guided neurolysis of celiac plexus, superior hypogastric plexus and ganglion impar. Of the 44 patients we studied, 20 underwent celiac plexus neurolysis, 18 superior hypogastric plexus neurolysis, and 6 ganglion impar neurolysis. Their pain was being managed with oral morphine before neurolysis, but only 11.4% patients required oral morphine for satisfactory pain control, 2 months after neurolysis. The mean Visual Analog Scale score before block placement was 5.64 ± 0.69 and fell to 2.25 ± 1.33 at 2 months post neurolysis (P &amp;lt; 0.001). We suggest that bedside ultrasonography‐guided sympathetic axis neurolysis may be employed early in patients with incur...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4872890</comments>
            <pubDate>Wed, 25 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4872890</guid>        </item>
        <item>
            <title>Health Care Costs in Patients with Fibromyalgia on Pregabalin vs. Duloxetine</title>
            <link>http://www.medworm.com/index.php?rid=4872889&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00470.x</link>
            <description>Conclusion:  No significant differences were found between pregabalin and duloxetine in the pre‐ to postindex change in mean all‐cause or fibromyalgia‐related total health care costs. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4872889</comments>
            <pubDate>Wed, 25 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4872889</guid>        </item>
        <item>
            <title>23. Pain in Patients with Cancer</title>
            <link>http://www.medworm.com/index.php?rid=4936021&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00473.x</link>
            <description>Abstract:  Pain in patients with cancer can be refractory to pharmacological treatment or intolerable side effects of pharmacological treatment may seriously disturb patients’ quality of life. Specific interventional pain management techniques can be an effective alternative for those patients. The appropriate application of these interventional techniques provides better pain control, allows the reduction of analgesics and hence improves quality of life. Until recently, the majority of these techniques are considered to be a fourth consecutive step following the World Health Organization’s pain treatment ladder. However, in cancer patients, earlier application of interventional pain management techniques can be recommended even before considering the use of strong opioids.Epidural a...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4936021</comments>
            <pubDate>Sat, 30 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4936021</guid>        </item>
        <item>
            <title>Scalene Muscle Injections for Neurogenic Thoracic Outlet Syndrome: Case Series</title>
            <link>http://www.medworm.com/index.php?rid=4894558&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00468.x</link>
            <description>Conclusions:  The relief from scalene muscle injections in patients with neurogenic thoracic outlet syndrome is not related to blockade of the brachial plexus. ▪ (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4894558</comments>
            <pubDate>Sat, 30 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4894558</guid>        </item>
        <item>
            <title>The Story of the Texas Pain Society: Formation and Function of a Regional Pain Society</title>
            <link>http://www.medworm.com/index.php?rid=4872888&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00472.x</link>
            <description>This report is the history of Texas Pain Society as the activities unfolded from 1989 to 2011.The reader may question why there is a need to tell such a story. We believe strongly that, with disparities of standards of practice in pain medicine and poor recognition of advances in pain management, this scenario is quite common in many states and countries. The practitioners of pain management in these regions certainly must have considered getting together and forming a consensus on the standards of practice in their communities. This historical report of the Texas Pain Society provides the relevant information necessary and the efforts to be made for a society’s mission to achieve its goals and have an ongoing impact in its own region. We hope that we have shed some light on a process fo...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4872888</comments>
            <pubDate>Sat, 30 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4872888</guid>        </item>
        <item>
            <title>Chronic Female Pelvic Pain—Part 1: Clinical Pathoanatomy and Examination of the Pelvic Region</title>
            <link>http://www.medworm.com/index.php?rid=4863558&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00465.x</link>
            <description>Abstract:  Chronic pelvic pain is defined as the presence of pain in the pelvic girdle region for over a 6‐month period and can arise from the gynecologic, urologic, gastrointestinal, and musculoskeletal systems. As 15% of women experience pelvic pain at some time in their lives with yearly direct medical costs estimated at $2.8 billion, effective evaluation and management strategies of this condition are necessary. This merits a thorough discussion of a systematic approach to the evaluation of chronic pelvic pain conditions, including a careful history‐taking and clinical examination. The challenge of accurately diagnosing chronic pelvic pain resides in the degree of peripheral and central sensitization of the nervous system associated with the chronicity of the symptoms, as well ...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4863558</comments>
            <pubDate>Sat, 30 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4863558</guid>        </item>
        <item>
            <title>In Response to Drs. Cone and Caplan: Regarding Urine Drug Testing</title>
            <link>http://www.medworm.com/index.php?rid=4790035&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00456_2.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4790035</comments>
            <pubDate>Sat, 30 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4790035</guid>        </item>
        <item>
            <title>Re: Pergolizzi et al., 2010: The Role of Urine Drug Testing for Patients on Opioid Therapy</title>
            <link>http://www.medworm.com/index.php?rid=4790034&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00456_1.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4790034</comments>
            <pubDate>Sat, 30 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4790034</guid>        </item>
        <item>
            <title>Analgesic Effectiveness of Dipyrone (Metamizol) for Postoperative Pain after Herniorrhaphy: A Randomized, Double‐Blind, Dose–Response Study</title>
            <link>http://www.medworm.com/index.php?rid=4735484&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00463.x</link>
            <description>Conclusion:  This trial shows a dose–response effect of 40 mg/kg over 15 mg/kg of intravenous dipyrone based on better movement‐induced pain control, lower morphine consumption and fewer opioid‐related side effects. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4735484</comments>
            <pubDate>Tue, 19 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4735484</guid>        </item>
        <item>
            <title>Preoperative vs. Postoperative Bilateral Paravertebral Blocks for Laparoscopic Cholecystectomy: A Prospective Randomized Clinical Trial</title>
            <link>http://www.medworm.com/index.php?rid=4654023&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00447.x</link>
            <description>Conclusion:  Bilateral paravertebral blockade performed prior to general anesthesia for laparoscopic cholecystectomy can provide early discharge and better postoperative pain management. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4654023</comments>
            <pubDate>Tue, 29 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4654023</guid>        </item>
        <item>
            <title>22. Traumatic Plexus Lesion</title>
            <link>http://www.medworm.com/index.php?rid=4654022&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00451.x</link>
            <description>Abstract:  Pain, motor, and sensory deficits characterize patients with a traumatic lesion of the brachial plexus. Frequently, more severe injuries co‐exist that require immediate surgical attention.Early rehabilitation and physical therapy are the cornerstones of treatment. Pharmacological management can be difficult. Surgical reconstruction is frequently advised when nerves are disrupted. The results, mostly from small historical reports, vary greatly. Neurostimulation may have an additional beneficial effect, especially if the pathophysiology of nociception and neuropathic pain becomes evident in these complex patients. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4654022</comments>
            <pubDate>Tue, 29 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4654022</guid>        </item>
        <item>
            <title>21. Phantom Pain</title>
            <link>http://www.medworm.com/index.php?rid=4654021&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00454.x</link>
            <description>Abstract:  Phantom pain is pain caused by elimination or interruption of sensory nerve impulses by destroying or injuring the sensory nerve fibers after amputation or deafferentation. The reported incidence of phantom limb pain after trauma, injury or peripheral vascular diseases is 60% to 80%. Over half the patients with phantom pain have stump pain as well. Phantom pain can also occur in other parts of the body; it has been described after mastectomies and enucleation of the eye.Most patients with phantom pain have intermittent pain, with intervals that range from 1 day to several weeks. Even intervals of over a year have been reported. The pain often presents itself in the form of attacks that vary in duration from a few seconds to minutes or hours. In most cases, the pain is experi...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4654021</comments>
            <pubDate>Tue, 29 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4654021</guid>        </item>
        <item>
            <title>Subcutaneous Target Stimulation–Peripheral Subcutaneous Field Stimulation in the Treatment of Refractory Angina: Preliminary Case Reports</title>
            <link>http://www.medworm.com/index.php?rid=4654020&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00455.x</link>
            <description>We present the use of an alternative approach to neuromodulation of anginal pain using subcutaneous leads placed at the site of pain. In this case series, five patients with refractory angina received successful treatment with subcutaneous target stimulation–peripheral subcutaneous field stimulation. This technique was able to provide good analgesia in two patients that had had poor pain relief from existing spinal cord stimulators. All five patients achieved significant pain relief with a reduction in symptoms and a decrease in the use of pain medication. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4654020</comments>
            <pubDate>Tue, 29 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4654020</guid>        </item>
        <item>
            <title>Pulmonary Cement Embolism after Kyphoplasty</title>
            <link>http://www.medworm.com/index.php?rid=4632160&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00446.x</link>
            <description>Abstract:  An 80‐year‐old female with a history of osteoporosis was evaluated for sudden onset axial low back pain with bilateral lower extremity weakness, hyperreflexia, pain, urinary retention, and decreased rectal tone. Computed tomography of the lumbar spine revealed L1 compression fracture, retropulsion of bone causing spinal canal compromise with associated severe central canal stenosis. Following cement kyphoplasty of L1 with polymethyl methacrylate, the patient developed tachycardia and dyspnea. Chest radiograph and computed tomographic pulmonary angiogram revealed a large collection of hyperdense material within the right lower lobe pulmonary artery, consistent with pulmonary cement emboli. Management and imaging are discussed. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4632160</comments>
            <pubDate>Fri, 25 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4632160</guid>        </item>
        <item>
            <title>The Pain Anxiety Symptoms Scale Fails to Discriminate Pain or Anxiety in a Chronic Disabling Occupational Musculoskeletal Disorder Population</title>
            <link>http://www.medworm.com/index.php?rid=4632159&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00448.x</link>
            <description>Conclusions:  The PASS is elevated when other measures of psychosocial distress are also elevated. However, the PASS fails to discriminate between different indices of depression and anxiety and it is not highly related to 1‐year outcomes in a CDOMD cohort. If time and resources are limited, a different measure of psychosocial distress that does relate to socioeconomic outcomes might be a better option in a CDOMD evaluation process. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4632159</comments>
            <pubDate>Fri, 25 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4632159</guid>        </item>
        <item>
            <title>19. Carpal Tunnel Syndrome</title>
            <link>http://www.medworm.com/index.php?rid=4632158&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00457.x</link>
            <description>Abstract:  Carpal tunnel syndrome (CTS) is a common disorder. In the majority of cases, patients with CTS can be diagnosed by means of appropriate history taking. Nerve conduction examination of the nervus medianus is the most important additional diagnostic test and is the best predictor of symptom severity and functional status in idiopathic CTS. Treatment option depends on the severity of the symptoms and the degree of functional daily limitations. If few limitations are present, splinting or corticosteroid injections are preferred. Surgical interventions are reserved for the more severe conditions resulting in significant disability.Interventional pain treatment such as pulsed radiofrequency could be an addition to the future treatment options for CTS. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4632158</comments>
            <pubDate>Fri, 25 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4632158</guid>        </item>
        <item>
            <title>20. Meralgia Paresthetica</title>
            <link>http://www.medworm.com/index.php?rid=4632157&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00458.x</link>
            <description>AbstractMeralgia paresthetica (MP) is a neurological disorder of the nervus cutaneous femoris lateralis (lateral femoral cutaneous nerve) (LFCN) characterized by a localized area of paresthesia and numbness on the anterolateral aspect of the thigh. Medical history and neurological examination are essential in making the diagnosis. However, red flags such as tumor and lumbar disc herniations must be ruled out. While the diagnosis of MP is essentially a clinical diagnosis, sensory nerve conduction velocity studies are a useful additional diagnostic tool.The first choice in management of MP is, besides treating the underlying cause, always a conservative approach. Simple measures such as losing weight and not wearing tight belts and/or trousers can be advised. Pharmacological therapy consists...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4632157</comments>
            <pubDate>Fri, 25 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4632157</guid>        </item>
        <item>
            <title>24. Chronic Refractory Angina Pectoris</title>
            <link>http://www.medworm.com/index.php?rid=4593555&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00444.x</link>
            <description>AbstractAngina pectoris, cardiac pain associated with ischemia, is considered refractory when optimal anti‐anginal therapy fails to resolve symptoms. It is associated with a decreased life expectancy and diminishes the quality of life. Spinal cord stimulation (SCS) may be considered for patients who have also undergone comprehensive interventions, such as coronary artery bypass graft (CABG) and percutaneous transluminal coronary angioplasty (PTCA) procedures.The mechanism of action of SCS is not entirely clear. Pain reduction is related to the increased release of inhibitory neuropeptides as well as normalization of the intrinsic nerve system of the heart muscle, and may have a protective myocardial effect.SCS in patients with refractory angina pectoris results in reduced anginal attacks...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4593555</comments>
            <pubDate>Tue, 15 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4593555</guid>        </item>
        <item>
            <title>Opioids: How to Improve Compliance and Adherence</title>
            <link>http://www.medworm.com/index.php?rid=4593554&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00449.x</link>
            <description>Abstract:  Chronic pain has been recognized as a major worldwide health care problem. Today, medical experts and health agencies agree that chronic pain should be treated with the same priority as the disease that caused it, and patients should receive adequate pain relief. To achieve good analgesia, patient adherence to a prescribed pain treatment is of high importance. Patients with chronic pain often do not use their medication as prescribed, but change the frequency of intake. This can result in poor treatment outcomes and may necessitate additional emergency treatment, which increases the overall costs.Factors that influence adherence include knowledge of the disease, realistic treatment expectations, perceived benefit from treatment, side effects, depression, dosing frequency, and ...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4593554</comments>
            <pubDate>Tue, 15 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4593554</guid>        </item>
        <item>
            <title>Clinical Characteristics, Pharmacotherapy, and Healthcare Resource Use among Patients with Diabetic Neuropathy Newly Prescribed Pregabalin or Gabapentin</title>
            <link>http://www.medworm.com/index.php?rid=4593553&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00450.x</link>
            <description>Conclusions:  Patients with pDPN prescribed pregabalin and gabapentin had a substantial comorbidity and pain medication burden. Although healthcare costs increased in both groups, the increase in pain medication burden was higher in the gabapentin group. Direct medical costs were similar for both groups. Given the human and economic burden of pDPN, future research may benefit from a focus on efficacy parameters to further differentiate treatment options. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4593553</comments>
            <pubDate>Tue, 15 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4593553</guid>        </item>
        <item>
            <title>Smoking Cessation and Chronic Pain: Patient and Pain Medicine Physician Attitudes</title>
            <link>http://www.medworm.com/index.php?rid=4754592&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00462.x</link>
            <description>Abstract:Although previous studies suggest that the clinical setting of an interdisciplinary pain treatment program may provide an optimal environment to promote smoking cessation, currently available smoking cessation interventions may be less effective for adults with chronic pain due, in part, to unrecognized clinical factors related to chronic pain. The specific aim of this qualitative study was to solicit information from adult smokers with chronic pain participating in an interdisciplinary pain treatment program regarding their perceptions of how smoking affects pain symptoms, and how these beliefs, cognitions, and emotions may either impede or facilitate smoking cessation. Similar information was solicited from a group of pain specialty physicians. The study involved 18 smokers with...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4754592</comments>
            <pubDate>Tue, 01 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4754592</guid>        </item>
        <item>
            <title>Higher Incidence of Common Diagnoses in Patients with Low Back Pain in Primary Care</title>
            <link>http://www.medworm.com/index.php?rid=4735483&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00466.x</link>
            <description>This study has an original design using data from family practices: the incidence of the most frequent diseases was compared in patients with and without LBP in 2004. The database includes data from 67 family physicians in 52 family practices in Flanders, Belgium. It contains data from 160,000 different patients with 1,500,000 diagnoses during the period 1994 to 2004. The incidence of the most frequent diagnoses is presented in patients with and without LBP in 2004. The diagnoses were coded according to the ICPC‐2‐classification.In 2004, the incidence of LBP was 51.4‰ (95% CI: 49.8 to 53.1) in patients aged 18 or older. The incidence was slightly higher in women than in men: 53.0‰ (95% CI: 50.7 to 55.4) vs. 49.9‰ (95% CI: 47.7 to 52.3). The highest incidence was recorded in the a...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4735483</comments>
            <pubDate>Tue, 01 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4735483</guid>        </item>
        <item>
            <title>Similar Studies with Different Conclusions: What’s a Reader to Believe?</title>
            <link>http://www.medworm.com/index.php?rid=4654019&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00461.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4654019</comments>
            <pubDate>Tue, 01 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4654019</guid>        </item>
        <item>
            <title>25. Ischemic Pain in the Extremities and Raynaud’s Phenomenon</title>
            <link>http://www.medworm.com/index.php?rid=4632156&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00460.x</link>
            <description>AbstractTwo important groups of disorders result from an insufficient blood supply to the extremities: critical vascular disease and the Raynaud’s phenomenon. The latter can be subdivided into a primary and a secondary type. Critical ischemic disease is often caused by arteriosclerosis due to hypertension or diabetes. Primary Raynaud’s is idiopathic and will be diagnosed as such if underlying systemic pathology has been excluded. Secondary Raynaud’s is often a manifestation of a systemic disease. It is essential to try to establish a diagnosis as soon as possible in order to influence the evolution of the disease.A sympathetic nerve block can be considered in patients with critical ischemic vascular disease after extensive conservative treatment, preferably in the context of a study ...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4632156</comments>
            <pubDate>Tue, 01 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4632156</guid>        </item>
        <item>
            <title>Quantitative Sensory Testing May Predict Response to Sphenopalatine Ganglion Pulsed Radiofrequency Treatment in Cluster Headaches: A Case Series</title>
            <link>http://www.medworm.com/index.php?rid=4593552&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00445.x</link>
            <description>We present our first three patients with long‐standing cluster headaches who were treated with pulsed radiofrequency to the sphenopalatine ganglion. All three patients have had cluster headaches for more than 10 years' duration and experienced minimal relief with conservative treatment. An excellent midterm effect was achieved in two of the three patients and a partial effect in one. No neurological side effects or complications were reported. Quantitative sensory testing consisting of allodynia testing, pressure–pain thresholds, electrical pain thresholds, and conditioned pain modulation (CPM) response testing were used to monitor their sensory processing changes before and after the procedure. From this case series, it might be that cluster headache patients with an impaired CPM resp...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4593552</comments>
            <pubDate>Tue, 01 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4593552</guid>        </item>
        <item>
            <title>Health Outcomes and Costs among Employees with Fibromyalgia Treated with Pregabalin vs. Standard of Care</title>
            <link>http://www.medworm.com/index.php?rid=4571421&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00453.x</link>
            <description>Conclusion:  Despite several comorbidity and drug use differences, most employee benefit outcomes and adherence did not differ between the cohorts. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4571421</comments>
            <pubDate>Tue, 01 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4571421</guid>        </item>
        <item>
            <title>Is migraine a complex regional pain syndrome of the brain? migraine prophylaxis with vitamin c?</title>
            <link>http://www.medworm.com/index.php?rid=4545402&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00442.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4545402</comments>
            <pubDate>Tue, 01 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4545402</guid>        </item>
        <item>
            <title>In response: urine drug screening and compliance</title>
            <link>http://www.medworm.com/index.php?rid=4545401&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00443_2.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4545401</comments>
            <pubDate>Tue, 01 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4545401</guid>        </item>
        <item>
            <title>Re: the role of urine drug testing for patients on opioid therapy</title>
            <link>http://www.medworm.com/index.php?rid=4545400&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00443_1.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4545400</comments>
            <pubDate>Tue, 01 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4545400</guid>        </item>
        <item>
            <title>A Pooled Analysis of Two Randomized, Double‐Blind, Placebo‐Controlled Trials of Milnacipran Monotherapy in the Treatment of Fibromyalgia</title>
            <link>http://www.medworm.com/index.php?rid=4545399&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00403.x</link>
            <description>AbstractMilnacipran has been shown to significantly improve the pain, global well‐being, and physical function of fibromyalgia (FM), and is approved by the U.S. Food and Drug Administration for the management of this disorder. Post hoc analyses of data from two pivotal trials were conducted to further assess the clinical benefits of milnacipran, to determine the impact of baseline pain severity on treatment outcomes, and to confirm the safety and tolerability of this medication in patients with FM. Patients in these trials were randomized to placebo (n = 624), milnacipran 100 mg/day (n = 623), or milnacipran 200 mg/day (n = 837). Two different composite responder analyses were used to evaluate efficacy: a 2‐measure analysis, requiring ≥ 30% improvement from baseline...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4545399</comments>
            <pubDate>Tue, 01 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4545399</guid>        </item>
        <item>
            <title>Modeling Neuropathic Pain: Subtlety and Susceptibility</title>
            <link>http://www.medworm.com/index.php?rid=4545398&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2011.00452.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4545398</comments>
            <pubDate>Tue, 01 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4545398</guid>        </item>
        <item>
            <title>Comparing Partial and Total Tibial‐Nerve Axotomy: Long‐Term Effects on Prevalence and Location of Evoked Pain Behaviors</title>
            <link>http://www.medworm.com/index.php?rid=4295180&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00429.x</link>
            <description>AbstractMonophasic (one‐time) nerve injuries heal without clinically significant residua in most cases, but rare individuals are left with neuropathic pain, even after seemingly minor lesions. The effects of lesion size on risk for chronic pain persistence are not well understood, particularly as concerns the complex regional pain syndrome, which is defined in part by pain “disproportionate” to the severity of the causative lesion, and extending outside the autonomous territory of a single nerve. To better clarify the expected prevalence of pain behaviors after nerve injury, we compared the effects in rats of different‐sized axotomies on the prevalence and location of evoked pain behaviors. To highlight clinical relevance, we also describe a patient with iatrogenic tibial‐nerve i...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4295180</comments>
            <pubDate>Wed, 29 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4295180</guid>        </item>
        <item>
            <title>Effect of Pregabalin in the Treatment of Refractory Neck Pain: Cost and Clinical Evidence from Medical Practice in Orthopedic Surgery and Rehabilitation Clinics</title>
            <link>http://www.medworm.com/index.php?rid=4295179&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00430.x</link>
            <description>Conclusion:  Compared with usual care, the addition of pregabalin to treat refractory neck pain seems to be associated with a higher reduction in pain severity and lost work‐days equivalents, which in turn results in a greater reduction of the indirect components of cost while maintaining similar healthcare cost levels despite its higher price. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4295179</comments>
            <pubDate>Wed, 29 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4295179</guid>        </item>
        <item>
            <title>Medication Adherence and Healthcare Costs among Fibromyalgia Patients Treated with Duloxetine</title>
            <link>http://www.medworm.com/index.php?rid=4295178&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00431.x</link>
            <description>Conclusion:  Fibromyalgia patients with higher duloxetine ADD were more likely to adhere to the therapy. High duloxetine adherence was associated with lower (Commercial) or similar (Medicare supplemental) healthcare costs. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4295178</comments>
            <pubDate>Wed, 29 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4295178</guid>        </item>
        <item>
            <title>Herpes Zoster Pain, Postherpetic Neuralgia, and Quality of Life in the Elderly</title>
            <link>http://www.medworm.com/index.php?rid=4295177&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00432.x</link>
            <description>AbstractHerpes zoster pain and postherpetic neuralgia (PHN) particularly affect older persons. This literature review presents how quality of life is evaluated and the consequences of shingles and PHN on the quality of life of older persons. Although more than 150 articles have been published on herpes zoster and its consequences, specific studies focusing on the older population are needed, in several domains like epidemiology, preventive medicine, neuropsychology, and pharmacology. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4295177</comments>
            <pubDate>Wed, 29 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4295177</guid>        </item>
        <item>
            <title>Anesthesiologists' Views on Using Immune Modulating Drugs in Pain Medicine</title>
            <link>http://www.medworm.com/index.php?rid=4295176&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00433.x</link>
            <description>AbstractWith few exceptions, anesthesiologists have not received training in the use of immune modulating drugs (IMDs); but recent evidence suggests that such drugs may be effective in reducing chronic pain. We therefore wished to learn how anesthesiologists working in pain medicine might envisage the treatment of their patients with IMDs in the future. We expected that anesthesiologists would want to refer patients for treatment with IMDs to medical colleagues, such as oncologists or rheumatologists, with prior experience in using these drugs, rather than treat these patients within their own practice. We conducted questionnaire surveys among anesthesiologists working in pain medicine in both the Netherlands and the U.K. to explore their views on using IMDs. Contrary to what we had expect...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4295176</comments>
            <pubDate>Wed, 29 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4295176</guid>        </item>
        <item>
            <title>Transdermal Buprenorphine for Central Neuropathic Pain: Clinical Reports</title>
            <link>http://www.medworm.com/index.php?rid=4295175&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00434.x</link>
            <description>We present two different painful conditions of presumed neuropathic origin, with complex etiopathogenesis, which were successfully treated with buprenorphine. The results of treatment of these neuropathic pain syndromes with buprenorphine are encouraging, suggesting that it might represent a valid alternative to standard approaches for central neuropathic pain. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4295175</comments>
            <pubDate>Wed, 29 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4295175</guid>        </item>
        <item>
            <title>Are Psychoactive Substance (Opioid)‐Dependent Chronic Pain Patients Hyperalgesic?</title>
            <link>http://www.medworm.com/index.php?rid=4295185&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00437.x</link>
            <description>Conclusions:  This study contributes to the human OIH literature. However, because of the potential confounders in this study, the issue of OIH in humans remains unresolved. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4295185</comments>
            <pubDate>Tue, 28 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4295185</guid>        </item>
        <item>
            <title>Exposure to Potential CYP450 Pharmacokinetic Drug–Drug Interactions among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions</title>
            <link>http://www.medworm.com/index.php?rid=4295184&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00438.x</link>
            <description>This study challenged previous assumptions about DDEs in that advanced age was not positively associated with the risk of DDE. However, the number of prescriptions the patient received in the 90‐day window prior to the index date was a risk factor. For patients taking at least two medications in the 90‐day period prior to the index date, every additional prescription taken increased their risk for a DDE during the observation period by 138% (on average). The risk of DDE during the study period was threefold greater for patients with one medication in the 90‐day period before index date compared with similar patients with no prescriptions in that same period before the index date. DDEs are more common than may be generally believed in patients with osteoarthritis, regardless of age, a...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4295184</comments>
            <pubDate>Tue, 28 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4295184</guid>        </item>
        <item>
            <title>Percutaneous Sacroplasty and Sacroiliac Joint Cementation under Fluoroscopic Guidance for Lower Back Pain Related to Sacral Metastatic Tumors with Sacroiliac Joint Invasion</title>
            <link>http://www.medworm.com/index.php?rid=4295183&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00439.x</link>
            <description>We present a 48‐year‐old female with intractable and incapacitating low back pain because of metastatic bone tumor in the left lateral side of S1 and S2 with left sacroiliac invasion. Imaging identified a metastatic invasion of the sacrum. Percutaneous sacroplasty, a safe and effective procedure for sacral‐insufficient fractures, was performed under fluoroscopy guidance. However, the expected pain relief was not achieved. At 1 month, the patient remained invalided by severe back pain, which was localized to the left sacroiliac joint. In a second procedure, the sacroiliac joint was cemented. Pain relief was complete, immediate, and sustained until the patient's death related to the underlying oncologic disease. No complications were observed.Few reports exist about the treatment of sa...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4295183</comments>
            <pubDate>Tue, 28 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4295183</guid>        </item>
        <item>
            <title>Real‐World Evaluation of Health‐Care Resource Utilization and Costs in Employees with Fibromyalgia Treated with Pregabalin or Duloxetine</title>
            <link>http://www.medworm.com/index.php?rid=4295182&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00440.x</link>
            <description>Conclusions:  The changes in health resource utilization and costs after initiation of pregabalin were not significantly different than the changes observed after initiation of duloxetine. These results not only demonstrate an overall similarity of resource utilization, but also suggest cost neutrality between pregabalin and duloxetine. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4295182</comments>
            <pubDate>Tue, 28 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4295182</guid>        </item>
        <item>
            <title>A Meta‐Analysis of Pain Response in the Treatment of Fibromyalgia</title>
            <link>http://www.medworm.com/index.php?rid=4295181&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00441.x</link>
            <description>Conclusion:  All eight active treatments displayed evidence suggesting improvement over placebo in the treatment of pain in patients suffering from fibromyalgia. Indirect comparison of active treatments found no strong differences. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4295181</comments>
            <pubDate>Tue, 28 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4295181</guid>        </item>
        <item>
            <title>Fluoroscopically Guided Supraglenoid Tubercle Steroid Injections for the Management of Biceps Tendonitis</title>
            <link>http://www.medworm.com/index.php?rid=4208310&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00424.x</link>
            <description>Discussion:  A fluoroscopically guided block injected into the supraglenoid tubercle may be effective in the management of bicipital tendonitis. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4208310</comments>
            <pubDate>Sun, 28 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4208310</guid>        </item>
        <item>
            <title>A Literature Review of Randomized Clinical Trials of Intravenous Acetaminophen (Paracetamol) for Acute Postoperative Pain</title>
            <link>http://www.medworm.com/index.php?rid=4208309&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00426.x</link>
            <description>Conclusion:  In aggregate, these data indicate that IV acetaminophen is an effective analgesic across a variety of surgical procedures. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4208309</comments>
            <pubDate>Sun, 28 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4208309</guid>        </item>
        <item>
            <title>Radiofrequency Ablation Within the First Intercoccygeal Disk for Coccygodynia: A Case Report</title>
            <link>http://www.medworm.com/index.php?rid=4179642&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00423.x</link>
            <description>Discussion:  There is evidence that intercoccygeal disks can be a source of coccydynia. Immunohistochemistry has shown mechanoreceptors in intercoccygeal disks, and coccygeal discography has been shown to reproduce coccygeal pain. Intercoccygeal disk injection is described as a therapeutic option in the literature. Because various RFA techniques have been successfully used for intervertebral diskogenic pain, the decision was made to attempt RFA at the 1st intercoccygeal disk with resultant significant long‐term improvement. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4179642</comments>
            <pubDate>Thu, 18 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4179642</guid>        </item>
        <item>
            <title>18. Painful Diabetic Polyneuropathy</title>
            <link>http://www.medworm.com/index.php?rid=4295174&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00435.x</link>
            <description>AbstractIn the industrialized world, polyneuropathy induced by diabetes mellitus (DM) is one of the most prevalent forms of neuropathy. Diabetic neuropathy can result from a direct toxic effect of glucose on nerve cells. Additionally, the damage of the nerve structures (central and peripheral) is accompanied by a microvascular dysfunction, which damages the vasa nervorum. More than 80% of the patients with DM‐induced polyneuropathy have a distal and symmetric presentation. The initial symptoms are: signs of diminished sensation, burning feet, which may occur particularly during the night and worsen when touched, and tingling sensation in the feet. Attacks of shooting pain may also occur.Proper control of DM is mandatory. Based on the recently published National Institute for Health and C...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4295174</comments>
            <pubDate>Mon, 01 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4295174</guid>        </item>
        <item>
            <title>Factor Structure of Pain Medication Questionnaire in Community‐Dwelling Older Adults with Chronic Pain</title>
            <link>http://www.medworm.com/index.php?rid=4242265&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00422.x</link>
            <description>Conclusion:  The findings suggest that, although a small number of the items were identified from the overall scale, they adequately explain two relatively unique factors pertaining to pain management among older adults. This preliminary study suggests that the seven‐item PMQ may be useful in assessing opioid medication misuse in community‐dwelling older adults with chronic pain. Future studies are needed to confirm the reliability, validity, and factor structure of this modified PMQ in the geriatric population. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4242265</comments>
            <pubDate>Mon, 01 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4242265</guid>        </item>
        <item>
            <title>17. Herpes Zoster and Post‐Herpetic Neuralgia</title>
            <link>http://www.medworm.com/index.php?rid=4208308&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00428.x</link>
            <description>The objectives of treating herpes zoster are: (1) acute pain reduction; (2) promotion of recovery of epidermal defects and prevention of secondary infections; and (3) reduction or prevention of post‐herpetic neuralgia.The objective of the treatment of post‐herpetic neuralgia is primarily pain alleviation and improvement of the quality of life.Early treatment of the infection and the pain is believed to reduce the risk for post‐herpetic neuralgia. This persistent pain syndrome is difficult to treat. Antiepileptic drugs and tricyclic antidepressants are the first choice.Interventional treatments, such as epidural injections of corticosteroids and local anesthetic drugs, have an effect on the acute pain but are of limited use in preventing post‐herpetic neuralgia. When conservative tr...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4208308</comments>
            <pubDate>Mon, 01 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4208308</guid>        </item>
        <item>
            <title>An Open‐Label Comparison of Nabilone and Gabapentin as Adjuvant Therapy or Monotherapy in the Management of Neuropathic Pain in Patients with Peripheral Neuropathy</title>
            <link>http://www.medworm.com/index.php?rid=4179641&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00427.x</link>
            <description>AbstractNeuropathic pain (NeP) is prevalent in patients with peripheral neuropathy (PN), regardless of etiology. We sought to compare the efficacy of the cannabinoid nabilone as either monotherapy or adjuvant therapy with a first‐line medication for NeP, gabapentin, in a patient population with PN‐NeP. Patients diagnosed with PN‐NeP were permitted to initiate monotherapy (nabilone or gabapentin) or add one of these two medications (adjuvant therapy) to their existing NeP treatment regimen in a non‐randomized open‐label nature. Baseline data collected included a primary outcome (visual analog scores [VAS] of pain) and secondary outcomes (quality of life [EuroQol 5 Domains and Short‐Form 36] assessments and assessments of sleep [Medical Outcomes Sleep Study Scale {MOSSS}], anxiet...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4179641</comments>
            <pubDate>Mon, 01 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4179641</guid>        </item>
        <item>
            <title>Health Care Provider Perceptions of Pain Treatment in Hispanic Patients</title>
            <link>http://www.medworm.com/index.php?rid=4155781&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00421.x</link>
            <description>AbstractDespite increasing numbers of Hispanic patients in the United States, this group continues to face disparities in access and quality of pain treatment. Although previous surveys have examined treatment disparities experienced by minority patients, none have provided a provider‐centric perspective on issues and concerns surrounding pain relief among pain patients of Hispanic/Latino origin. The goal of this study was to assess the relationship between provider characteristics (ie, Spanish fluency, Hispanic caseload size, and experience with Hispanic pain patients) and their perceptions of pain treatment in these patients. One hundred eighty‐seven health professionals completed an online survey. The major findings indicated that: (1) less than 20% of health professionals treating ...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4155781</comments>
            <pubDate>Mon, 01 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4155781</guid>        </item>
        <item>
            <title>Acknowledgments</title>
            <link>http://www.medworm.com/index.php?rid=4144413&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00436.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4144413</comments>
            <pubDate>Mon, 01 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4144413</guid>        </item>
        <item>
            <title>Why Is Urine Drug Testing Not Used More Often in Practice?</title>
            <link>http://www.medworm.com/index.php?rid=4109345&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00425.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4109345</comments>
            <pubDate>Fri, 29 Oct 2010 16:22:03 +0100</pubDate>
            <guid isPermaLink="false">4109345</guid>        </item>
        <item>
            <title>A Comparative Subjective Assessment Study of PENNSAID® and Voltaren Gel®, Two Topical Formulations of Diclofenac Sodium</title>
            <link>http://www.medworm.com/index.php?rid=3984180&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00420.x</link>
            <description>Abstract (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3984180</comments>
            <pubDate>Tue, 21 Sep 2010 05:19:40 +0100</pubDate>
            <guid isPermaLink="false">3984180</guid>        </item>
        <item>
            <title>Treatment of Chronic Pain by Long‐Acting Opioids and the Effects on Sleep</title>
            <link>http://www.medworm.com/index.php?rid=3984179&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00417.x</link>
            <description>Abstract (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3984179</comments>
            <pubDate>Tue, 21 Sep 2010 05:19:39 +0100</pubDate>
            <guid isPermaLink="false">3984179</guid>        </item>
        <item>
            <title>The Relation between the Duty Cycle and Anesthetic Effect in Lidocaine Iontophoresis Using Alternating Current</title>
            <link>http://www.medworm.com/index.php?rid=3984178&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00418.x</link>
            <description>Abstract (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3984178</comments>
            <pubDate>Tue, 21 Sep 2010 05:19:39 +0100</pubDate>
            <guid isPermaLink="false">3984178</guid>        </item>
        <item>
            <title>The Addition of Tramadol as a Second Opioid May Improve Pain Relief in Severe Osteoarthritis: A Prospective Study</title>
            <link>http://www.medworm.com/index.php?rid=3939102&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00384.x</link>
            <description>Abstract (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3939102</comments>
            <pubDate>Wed, 08 Sep 2010 05:05:51 +0100</pubDate>
            <guid isPermaLink="false">3939102</guid>        </item>
        <item>
            <title>14. Coccygodynia</title>
            <link>http://www.medworm.com/index.php?rid=3936778&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00404.x</link>
            <description>Abstract (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3936778</comments>
            <pubDate>Tue, 07 Sep 2010 05:05:51 +0100</pubDate>
            <guid isPermaLink="false">3936778</guid>        </item>
        <item>
            <title>Radiofrequency Treatment of the Sacroiliac Joint: Quo Vadis?</title>
            <link>http://www.medworm.com/index.php?rid=3984177&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00419.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3984177</comments>
            <pubDate>Tue, 31 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3984177</guid>        </item>
        <item>
            <title>Retrospective Review of 707 Cases of Spinal Cord Stimulation: Indications and Complications</title>
            <link>http://www.medworm.com/index.php?rid=3939101&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00407.x</link>
            <description>Abstract (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3939101</comments>
            <pubDate>Tue, 31 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3939101</guid>        </item>
        <item>
            <title>15. Discogenic Low Back Pain</title>
            <link>http://www.medworm.com/index.php?rid=3936777&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00408.x</link>
            <description>Abstract (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3936777</comments>
            <pubDate>Tue, 31 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3936777</guid>        </item>
        <item>
            <title>IMAGES IN PAIN PRACTICE: Technical and Imaging Report: Fluoroscopic Guidance for Diagnosis and Treatment of Lumbar Synovial Cyst</title>
            <link>http://www.medworm.com/index.php?rid=3904403&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00411.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3904403</comments>
            <pubDate>Fri, 27 Aug 2010 05:07:06 +0100</pubDate>
            <guid isPermaLink="false">3904403</guid>        </item>
        <item>
            <title>ORIGINAL ARTICLE: Comparison of Medication Adherence and Healthcare Costs between Duloxetine and Pregabalin Initiators among Patients with Fibromyalgia</title>
            <link>http://www.medworm.com/index.php?rid=3904402&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00412.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3904402</comments>
            <pubDate>Fri, 27 Aug 2010 05:07:05 +0100</pubDate>
            <guid isPermaLink="false">3904402</guid>        </item>
        <item>
            <title>ORIGINAL ARTICLE: Prevalence of Exposure to Potential CYP450 Pharmacokinetic Drug–Drug Interactions among Patients with Chronic Low Back Pain Taking Opioids</title>
            <link>http://www.medworm.com/index.php?rid=3904401&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00413.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3904401</comments>
            <pubDate>Fri, 27 Aug 2010 05:07:05 +0100</pubDate>
            <guid isPermaLink="false">3904401</guid>        </item>
        <item>
            <title>REVIEW: Fentanyl Buccal Tablet for Breakthrough Cancer Pain: Why Titrate?</title>
            <link>http://www.medworm.com/index.php?rid=3904400&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00414.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3904400</comments>
            <pubDate>Fri, 27 Aug 2010 05:07:04 +0100</pubDate>
            <guid isPermaLink="false">3904400</guid>        </item>
        <item>
            <title>Evidence‐Based Manual Therapy for Chronic Musculoskeletal Pain: The Challenges</title>
            <link>http://www.medworm.com/index.php?rid=3904399&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00416.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3904399</comments>
            <pubDate>Fri, 27 Aug 2010 05:07:04 +0100</pubDate>
            <guid isPermaLink="false">3904399</guid>        </item>
        <item>
            <title>Analgesic Techniques in Minor Painful Procedures in Neonatal Units: A Survey in Northern Italy</title>
            <link>http://www.medworm.com/index.php?rid=3824584&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00406.x</link>
            <description>This study found a low adherence to national and international guidelines for analgesia in minor procedures: the underuse of neonatal pain scales (33%), sucrose solution administration before heel lance (23.3%), topical anesthetics before venipuncture, or other analgesic techniques. The presence of written pain control guidelines in these regions of Northern Italy increased in recent years (from 25% to 66%). (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3824584</comments>
            <pubDate>Wed, 04 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3824584</guid>        </item>
        <item>
            <title>Opioid Utilization and Health‐Care Costs among Patients with Diabetic Peripheral Neuropathic Pain Treated with Duloxetine vs. Other Therapies</title>
            <link>http://www.medworm.com/index.php?rid=3834276&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00392.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3834276</comments>
            <pubDate>Sat, 31 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3834276</guid>        </item>
        <item>
            <title>A Double‐blind, Randomized, Placebo‐controlled Study of the Efficacy and Safety of Duloxetine for the Treatment of Chronic Pain Due to Osteoarthritis of the Knee</title>
            <link>http://www.medworm.com/index.php?rid=3834275&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00401.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3834275</comments>
            <pubDate>Sat, 31 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3834275</guid>        </item>
        <item>
            <title>Comparative Evaluation of Oxygen‐Ozone Therapy and Combined Use of Oxygen‐Ozone Therapy with Percutaneous Intradiscal Radiofrequency Thermocoagulation for the Treatment of Lumbar Disc Herniation</title>
            <link>http://www.medworm.com/index.php?rid=3834274&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00409.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3834274</comments>
            <pubDate>Sat, 31 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3834274</guid>        </item>
        <item>
            <title>A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial of Intravenous Ibuprofen (IV‐Ibuprofen) in the Management of Postoperative Pain Following Abdominal Hysterectomy</title>
            <link>http://www.medworm.com/index.php?rid=3834273&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00402.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3834273</comments>
            <pubDate>Sat, 31 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3834273</guid>        </item>
        <item>
            <title>A Pooled Analysis of Two Randomized, Double‐Blind, Placebo‐Controlled Trials of Milnacipran Monotherapy in theTreatment of Fibromyalgia</title>
            <link>http://www.medworm.com/index.php?rid=3834272&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00403.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3834272</comments>
            <pubDate>Sat, 31 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3834272</guid>        </item>
        <item>
            <title>Pulsed Radiofrequency Under Ultrasound Guidance for Persistent Stump‐Neuroma Pain</title>
            <link>http://www.medworm.com/index.php?rid=3834271&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00398.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3834271</comments>
            <pubDate>Sat, 31 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3834271</guid>        </item>
        <item>
            <title>13. Sacroiliac Joint Pain</title>
            <link>http://www.medworm.com/index.php?rid=3834270&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00394.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3834270</comments>
            <pubDate>Sat, 31 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3834270</guid>        </item>
        <item>
            <title>Comparison of Acupuncture to Injection for Myofascial Trigger Point Pain</title>
            <link>http://www.medworm.com/index.php?rid=3799831&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00396.x</link>
            <description>Conclusion:  Acupuncture, when compared with trigger point injection, combined with cyclobenzaprine chlorhydrate and sodium dipyrone provided similar pain relief and improvement in quality of life measures at 4 weeks. &amp;#x25AA; (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3799831</comments>
            <pubDate>Thu, 29 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3799831</guid>        </item>
        <item>
            <title>13.&amp;nbsp;Sacroiliac Joint Pain</title>
            <link>http://www.medworm.com/index.php?rid=3791697&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00394.x</link>
            <description>The sacroiliac joint accounts for approximately 16% to 30% of cases of chronic mechanical low back pain. Pain originating in the sacroiliac joint is predominantly perceived in the gluteal region, although pain is often referred into the lower and upper lumbar region, groin, abdomen, and/ or lower limb(s). Because sacroiliac joint pain is difficult to distinguish from other forms of low back pain based on history, different provocative maneuvers have been advocated. Individually, they have weak predictive value, but combined batteries of tests can help ascertain a diagnosis. Radiological imaging is important to exclude &quot;red flags&quot; but contributes little in the diagnosis. Diagnostic blocks are the diagnostic gold standard but must be interpreted with caution, because false-positive as well a...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3791697</comments>
            <pubDate>Mon, 26 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3791697</guid>        </item>
        <item>
            <title>12. Pain Originating from the Lumbar Facet Joints</title>
            <link>http://www.medworm.com/index.php?rid=3791698&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00393.x</link>
            <description>Although the existence of a &quot;facet syndrome&quot; had long been questioned, it is now generally accepted as a clinical entity. Depending on the diagnostic criteria, the zygapophysial joints account for between 5% and 15% of cases of chronic, axial low back pain. Most commonly, facetogenic pain is the result of repetitive stress and/or cumulative low-level trauma, leading to inflammation and stretching of the joint capsule. The most frequent complaint is axial low back pain with referred pain perceived in the flank, hip, and thigh. No physical examination findings are pathognomonic for diagnosis. The strongest indicator for lumbar facet pain is pain reduction after anesthetic blocks of the rami mediales (medial branches) of the rami dorsales that innervate the facet joints. Because false-positiv...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3791698</comments>
            <pubDate>Sun, 25 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3791698</guid>        </item>
        <item>
            <title>Comparative Evaluation of Oxygen-Ozone Therapy and Combined Use of Oxygen-Ozone Therapy with Percutaneous Intradiscal Radiofrequency Thermocoagulation for the Treatment of Lumbar Disc Herniation</title>
            <link>http://www.medworm.com/index.php?rid=3765099&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00409.x</link>
            <description>Conclusion:  Ozone-PIRFT is more efficacious than ozone alone in reducing pain scores, analgesic consumption, improving functional outcome, and satisfaction of patients with contained lumbar disc herniation. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3765099</comments>
            <pubDate>Mon, 19 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3765099</guid>        </item>
        <item>
            <title>Pulsed Radiofrequency Under Ultrasound Guidance for Persistent Stump-Neuroma Pain</title>
            <link>http://www.medworm.com/index.php?rid=3765103&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00398.x</link>
            <description>Limb amputation is a leading cause of pain and disability. Limb amputation can be associated with a myriad of symptoms, including phantom limb sensation, phantom limb pain, and stump pain. Treatment of phantom limb pain and stump pain, remains difficult, therefore optimal management must include a multidisciplinary approach. This case report describes the use of ultrasound for diagnosis and successful management, of persistent stump-neuroma pain, using pulsed radiofrequency ablation. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3765103</comments>
            <pubDate>Sun, 18 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3765103</guid>        </item>
        <item>
            <title>A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Ibuprofen (IV-Ibuprofen) in the Management of Postoperative Pain Following Abdominal Hysterectomy</title>
            <link>http://www.medworm.com/index.php?rid=3765102&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00402.x</link>
            <description>Conclusion:  This study demonstrated that IV-ibuprofen is an effective analgesic medication that is safe and well tolerated when administered as an 800 mg dose every 6 hours in patients undergoing total abdominal hysterectomy surgery. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3765102</comments>
            <pubDate>Sun, 18 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3765102</guid>        </item>
        <item>
            <title>A Pooled Analysis of Two Randomized, Double-Blind, Placebo-Controlled Trials of Milnacipran Monotherapy in theTreatment of Fibromyalgia</title>
            <link>http://www.medworm.com/index.php?rid=3765101&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00403.x</link>
            <description>Milnacipran has been shown to significantly improve the pain, global well-being, and physical function of fibromyalgia (FM), and is approved by the U.S. Food and Drug Administration for the management of this disorder. Post hoc analyses of data from two pivotal trials were conducted to further assess the clinical benefits of milnacipran, to determine the impact of baseline pain severity on treatment outcomes, and to confirm the safety and tolerability of this medication in patients with FM. Patients in these trials were randomized to placebo (n = 624), milnacipran 100 mg/day (n = 623), or milnacipran 200 mg/day (n = 837). Two different composite responder analyses were used to evaluate efficacy: a 2-measure analysis, requiring [ge] 30% improvement from baseline visual analog scale 24-hour ...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3765101</comments>
            <pubDate>Sun, 18 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3765101</guid>        </item>
        <item>
            <title>Meningismus Associated with Malpositioned Intraspinal Catheter for Drug Delivery</title>
            <link>http://www.medworm.com/index.php?rid=3765100&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00405.x</link>
            <description>Conclusion:  Meningismus from malpositioned catheters is a rare complication that can mimic meningitis but should be considered in the differential for postimplant headaches. Given the increased use of IDDS, it is important to recognize and evaluate postimplant complication and treat it appropriately. We discuss this case report and appropriate work-up and differential diagnosis for meningismus following implant. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3765100</comments>
            <pubDate>Sun, 18 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3765100</guid>        </item>
        <item>
            <title>A Double-blind, Randomized, Placebo-controlled Study of the Efficacy and Safety of Duloxetine for the Treatment of Chronic Pain Due to Osteoarthritis of the Knee</title>
            <link>http://www.medworm.com/index.php?rid=3727520&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00401.x</link>
            <description>Conclusions:  Treatment with duloxetine 60 mg to 120 mg QD was associated with significant pain reduction and improved function in patients with pain due to osteoarthritis of the knee. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3727520</comments>
            <pubDate>Tue, 06 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3727520</guid>        </item>
        <item>
            <title>Assessing Dimensionality and Responsiveness of Outcomes Measures for Patients with Low Back Pain</title>
            <link>http://www.medworm.com/index.php?rid=3727525&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00390.x</link>
            <description>Conclusions:  We identified 13 measures of LBP that can be used to evaluate responsiveness to change. Choice of a measure warrants careful evaluation of its construct and responsiveness properties in order to maximize the observed impact on pain and functional improvement in subjects with LBP. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3727525</comments>
            <pubDate>Sun, 04 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3727525</guid>        </item>
        <item>
            <title>Differences in Comorbidities on Low Back Pain and Low Back Related Leg Pain</title>
            <link>http://www.medworm.com/index.php?rid=3727524&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00391.x</link>
            <description>Conclusion:  The disability statuses of the patients with primary LBP in this study were more significantly affected by comorbidities of BMI, depression and smoking than patients with report of LBLP. However, these comorbidities contribute little to the relationship of primary low back related leg pain and Oswestry scores [ge] 40. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3727524</comments>
            <pubDate>Sun, 04 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3727524</guid>        </item>
        <item>
            <title>Opioid Utilization and Health-Care Costs among Patients with Diabetic Peripheral Neuropathic Pain Treated with Duloxetine vs. Other Therapies</title>
            <link>http://www.medworm.com/index.php?rid=3727523&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00392.x</link>
            <description>Conclusions:  DPNP patients who initiated duloxetine therapy were less likely to have subsequent opioid use and had lower health-care costs than SOC patients. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3727523</comments>
            <pubDate>Sun, 04 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3727523</guid>        </item>
        <item>
            <title>Validity and Reliability of the Arabic Adapted Version of the DN4 Questionnaire (Douleur Neuropathique 4 Questions) for Differential Diagnosis of Pain Syndromes with a Neuropathic or Somatic Component</title>
            <link>http://www.medworm.com/index.php?rid=3727522&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00399.x</link>
            <description>This study represents the second validation DN4 in a language different from the original after the Spanish adaptation. These results support the high discriminatory value of the DN4 questionnaire for identification of NP. (Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3727522</comments>
            <pubDate>Sun, 04 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3727522</guid>        </item>
        <item>
            <title>Bipolar Radiofrequency Lesion Geometry: Implications for Palisade Treatment of Sacroiliac Joint Pain</title>
            <link>http://www.medworm.com/index.php?rid=3727521&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00400.x</link>
            <description>Ex vivo photographic temperature mapping of bipolar radiofrequency (RF) lesions in animal tissue is performed over a wide range of electrode tip spacings, tip lengths, tip diameters, tip temperatures, and lesion times. In vivo temperature measurements collected during clinical treatment of sacroiliac joint (SIJ) pain corroborate those collected ex vivo. Generation of a &quot;strip lesion&quot; connecting two separated bipolar electrode tips is demonstrated ex vivo for tip spacings as large as 20 mm. A rounded rectangular bipolar lesion with midline dimensions 12 mm × 15 mm × 8 mm (L × W × D) is demonstrated using 10 mm parallel tip spacing, 10 mm tip lengths, 20 gauge cannulae, 90°C tip temperature, and 3-minute lesion time. Lesion length can be increased to 18 mm by using 15 mm tip lengths. Le...</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3727521</comments>
            <pubDate>Sun, 04 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3727521</guid>        </item>
        <item>
            <title>16. Complex Regional Pain Syndrome</title>
            <link>http://www.medworm.com/index.php?rid=3904398&amp;cid=s_28808_5_f&amp;fid=28808&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1533-2500.2010.00388.x</link>
            <description>(Source: Pain Practice)</description>
            <author>Pain Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3904398</comments>
            <pubDate>Wed, 30 Jun 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3904398</guid>        </item>
    </channel>
</rss>

